| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/07/2004 | US20040198741 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198736 Non-nucleoside reverse transcriptase inhibitors |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198730 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | DE10313118A1 Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese Enantioselective hydrogenation of intermediates in the synthesis of tipranavir |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | CA2520129A1 Enantioselective hydrogenation of intermediates in the synthesis of tipranavir |
| 10/07/2004 | CA2519401A1 Cannabinoid receptor ligands |
| 10/07/2004 | CA2519288A1 N-phenyl-[(4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 10/07/2004 | CA2518945A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 10/07/2004 | CA2518823A1 Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 10/06/2004 | EP1465020A2 Organophotoreceptor with a charge transport compound having an epoxy group |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents |
| 10/06/2004 | EP1463724A1 Pyrrolidone carboxamides |
| 10/06/2004 | EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof |
| 10/06/2004 | EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463506A1 Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1463501A1 Cis-imidazolines as mdm2 inhibitors |
| 10/06/2004 | EP1463440A2 Prevention of flap necrosis in plastic surgery |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1101755B1 Anthranilic acid derivatives |
| 10/06/2004 | EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 10/06/2004 | EP0970070B1 Phthalazines with angiogenesis inhibiting activity |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1535150A Novel use of 2-[5-(40fluorophenyl)3-pyridylmethylaminomethyl] |
| 10/06/2004 | CN1535139A Atorvastatin hemi-calcium form VII |
| 10/06/2004 | CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 10/06/2004 | CN1169797C Antiviral phrimidinedione derivatives and process for preparation thereof |
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/06/2004 | CN1169792C Substituted vinylpyridine derivatives and drugs containing the same |
| 10/06/2004 | CN1169791C Novel acetamide derivatives and protease inhibitors |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800651 Potentiators of glutamate receptors |
| 10/05/2004 | US6800646 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800639 Dioxolane nucleosides and nucleoside analogues such as troxacitabine together with chemotherapeutic agents other than doxorubicin such as cytarabine, gemcitabine and idarubicin; synergistic mixture; treating leukemia, cancer |
| 10/05/2004 | US6800628 Such as (1-(2-((3-methyl-2-pyrazinyl)amino)ethyl)-4-piperidinyl)-methyl-4-amino-5 -chloro-2,3-dihydro-7-benzofurancarboxylate |
| 10/05/2004 | CA2463719A1 Nucleotide analogs with six membered rings |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083204A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/30/2004 | WO2004083203A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | WO2004083199A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004082822A2 Methods for isolating crystalline form i of 5-azacytidine |
| 09/30/2004 | WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 09/30/2004 | WO2004082683A1 Therapeutic and/or preventive agent for chronic skin disease |
| 09/30/2004 | WO2004082682A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/30/2004 | WO2004058705B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192930 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis |
| 09/30/2004 | US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating |
| 09/30/2004 | US20040192927 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
| 09/30/2004 | US20040192924 3-(3-oxy-4-methoxy(pyridin-2-yl)-7-benzyl-2,6-dioxo-1,5-dioxon ane derivatives; fungicides |
| 09/30/2004 | US20040192767 EP4 receptor antagonists |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192753 Methods of use of thrombin receptor antagonists |
| 09/30/2004 | US20040192748 Heterocyclic compounds |
| 09/30/2004 | US20040192747 Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192735 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 09/30/2004 | US20040192734 Antiinflammatory agents; inflammatory bowel disorders; antihistamines;vision defects; antihistamines; skin disorders; oral diseases; antidiabetic agents; multiple sclerosis; antiulcer agents |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192729 Purification of antibodiees; elisa; neurotransmitter research; antidiabetic agents; skin disorders; antiinflammatory agents; antihistamines |
| 09/30/2004 | US20040192728 Antiinflammatory agents; analgesics |
| 09/30/2004 | US20040192712 Insecticides; for human or veterinary medicine |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
| 09/30/2004 | US20040192689 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192684 Ultraviolet light absorbers |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192672 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 09/30/2004 | US20040192654 use of nucleoside analogues as an effective treatment for acute or chronic myelogenous leukemia; (-)- beta -L-Dioxolane-Cytidine ( beta -L-oddC); (-)- beta -Dioxolane-5-fluoro-Cytidine (5-FddC) |
| 09/30/2004 | US20040192612 For treating diseases of the central nervous system, preserving organ transplant tissues or blood; treating cancer via immunotherapy; various other autoimmune, cardiovascular, and viral diseases; 1-oxo-1H-isoquinoline pro-drug esters, amides, or hydroxamides that cross the blood brain barrier |
| 09/30/2004 | US20040191668 Novel dyes and use thereof in imaging members and methods |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | CA2519444A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |